Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Intellia Therapeutics Inc (NASDAQ: NTLA) closed at $12.02 in the last session, down -3.61% from day before closing price of $12.47. In other words, the price has decreased by -$3.61 from its previous closing price. On the day, 1.89 million shares were traded. NTLA stock price reached its highest trading level at $12.25 during the session, while it also had its lowest trading level at $11.84.
Ratios:
We take a closer look at NTLA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.73 and its Current Ratio is at 6.73. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 23, 2024, Downgraded its rating to Neutral and sets its target price to $32 from $136 previously.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $66.Canaccord Genuity initiated its Buy rating on April 13, 2023, with a $66 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 03 ’25 when Dube Michael P sold 1,372 shares for $12.18 per share. The transaction valued at 16,711 led to the insider holds 45,640 shares of the business.
BASTA JAMES sold 7,074 shares of NTLA for $86,161 on Jan 03 ’25. The EVP, General Counsel now owns 74,497 shares after completing the transaction at $12.18 per share. On Jan 03 ’25, another insider, Lebwohl David, who serves as the EVP, Chief Medical Officer of the company, sold 9,557 shares for $12.18 each. As a result, the insider received 116,404 and left with 87,666 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTLA now has a Market Capitalization of 1224225024 and an Enterprise Value of 667728832. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.41 while its Price-to-Book (P/B) ratio in mrq is 1.27. Its current Enterprise Value per Revenue stands at 15.498 whereas that against EBITDA is -1.266.
Stock Price History:
Over the past 52 weeks, NTLA has reached a high of $34.87, while it has fallen to a 52-week low of $11.34. The 50-Day Moving Average of the stock is -14.41%, while the 200-Day Moving Average is calculated to be -41.98%.
Shares Statistics:
According to the various share statistics, NTLA traded on average about 2.67M shares per day over the past 3-months and 2310280 shares per day over the past 10 days. A total of 101.80M shares are outstanding, with a floating share count of 100.10M. Insiders hold about 1.71% of the company’s shares, while institutions hold 92.42% stake in the company. Shares short for NTLA as of 1734048000 were 19807004 with a Short Ratio of 7.41, compared to 1731628800 on 16365436. Therefore, it implies a Short% of Shares Outstanding of 19807004 and a Short% of Float of 22.15.
